Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.1 USD | -0.96% | +7.83% | +3.33% |
05-10 | Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-08 | Cassava Sciences Raises More Than $125 Million From Warrant Distribution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.33% | 1.12B | |
+7.40% | 111B | |
+11.40% | 106B | |
-12.50% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.46% | 16.81B | |
+38.13% | 12.54B | |
-24.25% | 8.09B |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.
- Cassava Sciences Completes Enrollment of 804 Participants for 12-Month Phase 3 Alzheimer's Trial